학술논문
1424MO Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma– Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM
Document Type
Abstract
Author
Source
In Annals of Oncology September 2020 31 Supplement 4:S901-S901
Subject
Language
ISSN
0923-7534